Nearly 52% of patients diagnosed with cervical cancer between 2012 and 2015 survived, says a study published in The Lancet Regional Health Southeast Asia, based on data from the Population-Based Cancer Registries across India, a report said.
Various urban PBCRs from different regions of India were assessed to find the survival rates of cervical cancer patients and it found that there was significant variations in survival rates across these regions.
Among those that participated in the study, the Ahmedabad urban registry demonstrated the highest survival rate at 61.5%, followed by Thiruvananthapuram with 58.8% and Kollam at 56.1% and in contrast, Tripura reported a survival rate of 31.6%.
The study focused on a total of 5,591 cervical cancer cases diagnosed between 2012 and 2015 in 11 PBCRs. The overall survival rate for these cases was 52%, which marked a notable improvement of approximately 6% compared with the previous SurvCan survey-3, where the survival rate was recorded at 46%, the report stated.
Survival rates were notably lower in India’s northeastern region.
Factors including access to diagnostic services, effective treatment varied across the population, distance from clinical care facilities, travel costs, co-morbidities, and poverty contributed to survival rates, noted the study. A research team, including scientists from the National Centre for Disease Informatics and Research and the ICMR, conducted a comprehensive study on cervical cancer in India.